cyclosporine has been researched along with Breast Neoplasms in 90 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 29 (32.22) | 18.2507 |
| 2000's | 38 (42.22) | 29.6817 |
| 2010's | 17 (18.89) | 24.3611 |
| 2020's | 6 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, S; Litman, T; Nagy, Z; Ozvegy, C; Sarkadi, B; Szakács, G; Váradi, A | 1 |
| Cerqueira, F; Florêncio, MH; Justino, F; Marcelo-Curto, MJ; Moiteiro, C; Nascimento, MS; Pedro, M; Pinto, MM; Tavares, R | 1 |
| Azzariti, A; Berardi, F; Cantore, M; Colabufo, NA; Contino, M; Inglese, C; Niso, M; Paradiso, A; Perrone, MG; Perrone, R; Porcelli, L; Simone, GM | 1 |
| Müller, H; Pick, A; Wiese, M | 1 |
| Juvale, K; Kraege, S; Ross, T; Stefan, K; Wiese, M; Willmes, T | 1 |
| Cui, ZN; Jin, HW; Li, YS; Liao, YX; Liu, XY; Song, GP; Zhao, DS | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Bitgen, N; Caner, A; Onal, MG; Sezer, G | 1 |
| Anderson, MS; Bertz, R; Bhardwaj, R; Collins, JL; Coric, V; Croop, R; Finley, JA; Madonia, J; Stock, DA; Stringfellow, J | 1 |
| Al Zouabi, HA; Alghfeli, A; Alsawaf, S; Hodeify, R; Marton, J; Matar, R; Mathew, S; Merheb, M; Ragupathi, NKD; Sethuvel, DPM; Siddiqui, SS; Vazhappilly, CG | 1 |
| Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H | 1 |
| Cassano, R; Curcio, F; Pellegrino, M; Poerio, T; Russo, R; Trombino, S | 1 |
| Jarrett, P; Locke, M; Patel, DK | 1 |
| Broer, PN; Ehrl, DC; Heidekrueger, PI | 1 |
| Ghahremani, MH; Khedri, A; Montazeri, H; Ostad, SN; Sepand, MR; Shadboorestan, A; Tarfiei, GA; Zangooei, M | 1 |
| Beijnen, JH; Helgason, HH; Huitema, AD; Koolen, SL; Kruijtzer, CM; Malingre, MM; Schellens, JH; Schot, ME; Smit, WM; Werkhoven, Ev | 1 |
| Chen, M; Cui, Z; Gao, W; Lin, Z; Yang, X; Yuan, L; Zhang, Q; Zhang, X | 1 |
| Acunas, G; Bulakci, M; Demir, AA; Gocmez, A; Salmaslioglu, A; Tukenmez, M; Yavuz, E | 1 |
| Alexander, B; Rout, P; Satish, R | 1 |
| Ata, P; Demir, T; Eriş, C; Gökçe, AM; Kara, M; Özdemir, E; Ozel, L; Titiz, MI | 1 |
| Grimm, M; Javadov, S; Kuznetsov, AV; Margreiter, R; Saks, V | 1 |
| Clevenger, CV; Dutson, LV; Feeney, YB; Koblinski, JE; Zheng, J | 1 |
| Hazra, B; Kumar, A; Kumar, B; Mishra, KP; Pandey, BN | 1 |
| Allshire, A; Anoopkumar-Dukie, S; Conere, T; Sisk, GD | 1 |
| Bailey, JG; Coyne, CP; Ross, MK | 1 |
| Cheng, F; Kong, LB; Li, XC; Qin, JJ; Sun, BC; Wang, XH; Yu, MN; Zhang, F | 1 |
| Angelico, R; Bellini, I; De Luca, L; Iaria, G; Manuelli, M; Perrone, L; Pisani, F; Sforza, D; Tisone, G | 1 |
| Alberú-Gómez, J; Medina-Franco, H; Rojas-García, P | 1 |
| Dietrich, CF; Hocke, M; Selbach, J | 1 |
| Chen, Q; Guo, Q; He, B; Jiang, K; Lai, L; Liu, Y; Wang, Q | 1 |
| Guo, B; Heibein, AD; Maclean, DA; Parissenti, AM; Sprowl, JA | 1 |
| Kim, CK; Lim, SJ; Simeone, AM; Tari, AM | 1 |
| Dry, J; Moroz, K; Zhang, JW | 1 |
| Balal, M; Karayaylali, I; Paydas, S; Seyrek, N | 1 |
| Cho, N; Jung, WH; Kim, EK; Kim, SH; Lee, JD; Oh, KK; Son, EJ | 1 |
| Goffin, E; Kanaan, N | 1 |
| Bright, EC; Hess, AD; Miura, Y; Thoburn, CJ | 1 |
| Ejendal, KF; Hrycyna, CA | 1 |
| Baer, MR; Fricke, SM; Greco, WR; Minderman, H; O'Loughlin, KL; Qadir, M; Williamson, NA | 1 |
| Chew, HK; DeNardo, GL; Denardo, SJ; Goldstein, DS; Kukis, DL; Lamborn, KR; Lara, PN; Meares, CF; Natarajan, A; O'Donnell, RT; Richman, CM; Shen, S; Tuscano, JM; Wun, T; Yuan, A | 1 |
| Akgul, E; Balal, M; Binokay, F; Demir, E; Paydas, S; Sertdemir, Y; Soyupak, S | 1 |
| Dai, Y; Gupta, A; Hebert, MF; Mao, Q; Ross, DD; Thummel, KE; Unadkat, JD; Vethanayagam, RR | 1 |
| Toker, A; Yiu, GK | 1 |
| Beijnen, JH; Helgason, HH; Huitema, AD; Kruijtzer, CM; Marcus, SG; Schellens, JH; Schornagel, JH; Schot, ME; ten Bokkel Huinink, WW | 1 |
| Decico, JE; Enokihara, MY; Floriano, M; Konishi, CT; Michalany, NS; Tomimori-Yamashita, J; Yarak, S | 1 |
| Cohen, DJ; Donovan, D; Hesdorffer, CS; Lo, KS; Nichols, G; Savage, D; Tiersten, A; Troxel, A; Vahdat, LT; Zipin, D | 1 |
| Banerjee, S; Bhattacharyya, A; Bhattacharyya, S; Chakraborty, J; Chattopadhyay, S; Choudhuri, T; Das, T; Lahiry, L; Mandal, D; Sa, G; Saha, B | 1 |
| Altmann, M; Diehl, E; Edwards, DP; Milad, M; Nordeen, S; Sullivan, W; Toft, DO | 1 |
| Cornblatt, B; Doyle, LA; Ross, DD; Tong, Y; Yang, W | 1 |
| Berlion, M; Dieterlen, A; Lucas, C; Marchal, S; Merlin, JL; Poullain, MG; Ramacci, C; Schultz, G | 1 |
| Grayson, H; Henderson, R; Opelz, G; Stewart, T; Tsai, SC | 1 |
| Lucas, C; Marchal, S; Merlin, JL; Paraire, M; Poullain, MG; Ramacci, C | 1 |
| Bright, E; Fischer, A; Hess, A; Jones, R; Kennedy, MJ; Morris, L; Ruvolo, P; Vogelsang, G | 1 |
| Altomonte, V; Davidson, NE; Farmer, ER; Hess, AD; Huelskamp, AM; Jones, RJ; Kennedy, MJ; Vogelsang, GB | 1 |
| Carmichael, J; Harris, AL; Kirk, J; Stratford, IJ | 1 |
| Kennedy, MJ | 1 |
| Delanian, S; Housset, M; Marie, JP; Maulard, C | 1 |
| Jones, RJ; Kennedy, MJ | 1 |
| Altomonte, V; Beveridge, RA; Davidson, NE; Farmer, ER; Huelskamp, AM; Kennedy, MJ; Vogelsang, GB | 1 |
| Mark, PJ; Martin, RL; Minchin, RF; Ratajczak, T | 1 |
| Altomonte, V; Horn, TD; Kennedy, MJ; Vogelsang, G | 1 |
| Ogretmen, B; Safa, AR | 1 |
| Baumgart, J; Harstrick, A; Scheulen, ME; Schleucher, N; Schroeder, J; Seeber, S; Vanhoefer, U; Wilke, H | 1 |
| Claudio, JA; Emerman, JT | 1 |
| Cohen, D; Kokubu, N; Watanabe, T | 1 |
| Ackrill, P; Baildam, AD; Furlong, A; Higgins, RM; Hurley, E; Mansel, RE; Venning, MC; Walls, J | 1 |
| Abraham, JM; Balcer-Kubiczek, EK; Han, LH; Harrison, GH; Meltzer, SJ; Shi, ZM; Zhang, XF | 1 |
| Abrams, B; Bleehen, SS; Bräutigam, M; Burrows, D; Ettelt, MJ; Fry, L; Ganslandt, J; Happle, R; Haustein, UF; Jung, EG; Knop, J; Kühne, KH; Mellein, B; Mørk, NJ; Rogers, S; Schmidt, AG; Schopf, RE; Sumner, M; Taube, KM; Weidinger, G; Wurdel, C; Zachariae, H; Zahn, E | 1 |
| Paquet, P; Piérard, GE | 1 |
| Campbell, A; Ditkoff, BA; Estabrook, A; Kurtz, E; Moazami, N; Schnabel, F | 1 |
| Clarkson, AR; Gill, PG; Kollias, J; Leong, AS | 1 |
| de Giuli, R; Lehnert, M; Twentyman, PR | 1 |
| Cabot, MC; Giuliano, AE; Han, TY; Liu, YY; Lucci, A | 1 |
| Boniface, GR; DeNardo, GL; DeNardo, SJ; Goldstein, DS; Griffith, IJ; Kroger, LA; Kukis, DL; O'Donnell, RT; Richman, CM; Shen, S; Yuan, A | 1 |
| Chen, Z; Fei, H; He, Z; Liu, S; Shen, Z; Yuan, J | 1 |
| Frame, JD; MacKenzie, D; Moiemen, N | 1 |
| Delaney, MP; Higgins, RM; Morris, AG; Smythe, E | 1 |
| Altomonte, V; Armstrong, DK; Bond, S; Bright, E; Clarke, B; Davidson, NE; Davis, JM; Fetting, J; Hess, AD; Horn, T; Kennedy, MJ; Lee, SM; McIntyre, K; Noga, SJ; Ohly, KV; Passos-Coehlo, JL; Thomassen, J; van der Wall, E; Vogelsang, G | 1 |
| Baron, F; Beguin, Y; Fillet, G; Gothot, A; Hermanne, JP; Pierard, GE; Salmon, JP | 1 |
| Bernhardt, G; Schlemmer, R; Schönenberger, H; Spruss, T | 1 |
| Hinterberger-Fischer, M | 1 |
| Beijnen, JH; Duchin, K; Koopman, FJ; Lieverst, J; Malingré, MM; Rosing, H; Schellens, JH; Swart, M; ten Bokkel Huinink, WW; van Tellingen, O | 1 |
| Datta, R; Lam, A; Srivastava, RK; Suliman, A | 1 |
| Aldridge, J; Diah, SK; Morrow, CS; Schneider, E; Smitherman, PK; Townsend, AJ; Volk, EL | 1 |
| Bright, EC; Hess, AD; Lefell, S; Miura, Y; Nakao, S; Sommer, M; Thoburn, CJ; Ueda, M | 1 |
| Collazzo, L; Conant, EF; Czerniecki, B; Lawton, TJ; Orel, SG; Weinstein, SP | 1 |
| Bohlen, P; Green, SK; Hicklin, D; Huang, P; Kerbel, RS; Klement, G; Man, S; Mayer, B | 1 |
| Chaiwun, B; Lumlertgul, D; Muttarak, M; Peh, WC | 1 |
| Baur, S; Schöfer, H | 1 |
| Carpentier, Y; Desoize, B; Gorisse, MC | 1 |
5 review(s) available for cyclosporine and Breast Neoplasms
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Pyoderma gangrenosum after breast surgery: A systematic review.
Topics: Autoimmune Diseases; Breast Neoplasms; Cyclosporine; Dermatologic Agents; Diagnostic Errors; Female; Fever; Glucocorticoids; Humans; Immunosuppressive Agents; Leukocytosis; Mammaplasty; Mastectomy; Postoperative Complications; Pyoderma Gangrenosum; Skin Transplantation; Surgical Wound Infection; Time-to-Treatment | 2018 |
Induced autologous graft-versus-host disease for the treatment of cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy; Interferon-gamma; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Rats; Transplantation, Autologous | 1994 |
Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.
Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunotherapy; Interferon-gamma | 1993 |
11 trial(s) available for cyclosporine and Breast Neoplasms
| Article | Year |
|---|---|
P-Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects.
Topics: ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cross-Over Studies; Cyclosporine; Female; Healthy Volunteers; Humans; Membrane Transport Proteins; Neoplasm Proteins; Piperidines; Pyridines; Quinidine | 2022 |
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Phase II and pharmacological study of oral docetaxel plus cyclosporin A in anthracycline pre-treated metastatic breast cancer.
Topics: Administration, Oral; Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Cyclosporine; Docetaxel; Drug Monitoring; Female; Humans; Middle Aged; Neoplasm Metastasis; Survival Rate; Taxoids; Treatment Outcome | 2014 |
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Cathepsins; Combined Modality Therapy; Cyclosporine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Mice; Middle Aged; Neutropenia; Paclitaxel; Prostatic Neoplasms; Radioimmunotherapy; Soft Tissue Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Cyclosporine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Metastasis; Paclitaxel; Survival Analysis; Treatment Outcome | 2006 |
Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Carboplatin; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Immunotherapy; Injections, Intravenous; Interferon-gamma; Interleukin-2; Middle Aged; Peripheral Blood Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation Conditioning | 2007 |
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Topics: Adult; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; HLA-DR Antigens; Humans; Interferon-gamma; Middle Aged; Prospective Studies; Skin; Treatment Outcome | 1994 |
Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Infusions, Intravenous; Middle Aged; Transplantation, Autologous | 1993 |
Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Chemistry, Pharmaceutical; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Evaluation; Emulsions; Female; Humans; Immunosuppressive Agents; Kidney Calculi; Leg; Male; Menorrhagia; Middle Aged; Pain; Psoriasis; Treatment Outcome | 1998 |
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cyclophosphamide; Cyclosporine; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Interferon-gamma; Killer Cells, Natural; Lymphocytes; Middle Aged; Phytohemagglutinins; Survival Analysis; Thiotepa | 2000 |
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carcinoma, Small Cell; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Paclitaxel; Premedication; Stomach Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 2001 |
75 other study(ies) available for cyclosporine and Breast Neoplasms
| Article | Year |
|---|---|
Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Membrane; Cloning, Molecular; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Recombinant Proteins; Spodoptera; Tumor Cells, Cultured | 2001 |
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Lung Neoplasms; Lymphocytes; Magnetic Resonance Spectroscopy; Melanoma; Molecular Structure; Oxidation-Reduction; Portugal; Quercus; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2001 |
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
Topics: Acridines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Female; Humans; Isoquinolines; Ligands; Quinolines; Structure-Activity Relationship; Tetrahydroisoquinolines | 2008 |
Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2).
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Models, Molecular; Molecular Structure; Neoplasm Proteins; Phthalic Acids; Quantitative Structure-Activity Relationship; Quinolines; Reproducibility of Results; Stereoisomerism; Time Factors; Tumor Cells, Cultured | 2008 |
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2).
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Chalcones; Cytotoxins; Female; Humans; Neoplasm Proteins; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
Synthesis and biological evaluation of 2,5-disubstituted furan derivatives as P-glycoprotein inhibitors for Doxorubicin resistance in MCF-7/ADR cell.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Female; Furans; Humans; MCF-7 Cells; Molecular Docking Simulation; Structure-Activity Relationship; Tetrahydroisoquinolines | 2018 |
The Effect of Cyclosporine A on Proteins Controlling Intracellular Calcium Concentration in Breast Cancer Cells.
Topics: Breast Neoplasms; Calcineurin; Calcium; Calcium Signaling; Cyclosporine; Female; Humans | 2022 |
Differential dose-response effect of cyclosporine A in regulating apoptosis and autophagy markers in MCF-7 cells.
Topics: Apoptosis; Autophagy; Breast Neoplasms; Cyclosporine; Female; Humans; MCF-7 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2 | 2023 |
Chitosan Membranes Filled with Cyclosporine A as Possible Devices for Local Administration of Drugs in the Treatment of Breast Cancer.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Cyclosporine; Drug Carriers; Humans; Membranes; Swine | 2021 |
Pyoderma gangrenosum with pathergy: A potentially significant complication following breast reconstruction.
Topics: Adult; Aged; Algorithms; Breast Neoplasms; Cicatrix; Cyclosporine; Debridement; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Mammaplasty; Mastectomy; Methylprednisolone; Middle Aged; Postoperative Complications; Prednisone; Pyoderma Gangrenosum; Young Adult | 2017 |
Invasion and migration of MDA-MB-231 cells are inhibited by block of AhR and NFAT: role of AhR/NFAT1/β4 integrin signaling.
Topics: Benzo(a)pyrene; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Environmental Pollutants; Humans; Integrin beta4; Neoplasm Invasiveness; NFATC Transcription Factors; Receptors, Aryl Hydrocarbon; Signal Transduction | 2019 |
The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cyclosporine; Doxorubicin; Female; Humans; Intracellular Space; Liposomes; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Tissue Distribution | 2014 |
Fibroadenomatosis involving bilateral breasts and axillary accessory breast tissues in a renal transplant recipient given cyclosporin A.
Topics: Breast Neoplasms; Cyclosporine; Female; Fibroadenoma; Humans; Image-Guided Biopsy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Transplant Recipients; Ultrasonography, Mammary | 2014 |
Double primary carcinoma in a renal allograft recipient.
Topics: Allografts; Azathioprine; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Prednisolone; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy.
Topics: Adult; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Cyclosporine; Early Detection of Cancer; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Retroperitoneal Neoplasms; Sarcoma, Kaposi; Sirolimus; Steroids; Tacrolimus; Thyroid Neoplasms; Time Factors; Urologic Neoplasms | 2015 |
Synchronism in mitochondrial ROS flashes, membrane depolarization and calcium sparks in human carcinoma cells.
Topics: Adenocarcinoma; Antioxidants; Breast Neoplasms; Calcium Signaling; Cell Line, Tumor; Colonic Neoplasms; Cyclosporine; Fluoresceins; Humans; Membrane Potential, Mitochondrial; Microscopy, Confocal; Microscopy, Fluorescence; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Photochemistry; Reactive Oxygen Species; Recombinant Proteins; Rhodamines; Single-Cell Analysis; Superoxide Dismutase | 2017 |
Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.
Topics: Animals; Breast Neoplasms; Cells, Cultured; Cyclophilin A; Cyclosporine; Disease Progression; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Mice; Mice, Nude; Peptidylprolyl Isomerase; Prolactin; Transplantation, Heterologous | 2008 |
Role of mitochondrial oxidative stress in the apoptosis induced by diospyrin diethylether in human breast carcinoma (MCF-7) cells.
Topics: Acetylcysteine; Allopurinol; Animals; Antimycin A; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cardiolipins; Cell Line, Tumor; Cyclosporine; Cytochromes c; Female; Free Radical Scavengers; Humans; Membrane Potential, Mitochondrial; Mitochondria; Naphthoquinones; Oxidation-Reduction; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Rotenone; Uncoupling Agents; Vitamin K 3 | 2009 |
Mitochondrial modulation of oxygen-dependent radiosensitivity in some human tumour cell lines.
Topics: Anti-Bacterial Agents; bcl-2-Associated X Protein; Bongkrekic Acid; Breast Neoplasms; Cell Line, Tumor; Cyclosporine; Female; Humans; Immunosuppressive Agents; Melanoma; Mitochondria; Oxidative Stress; Radiation Tolerance; Tacrolimus; Uterine Cervical Neoplasms | 2009 |
Dual potency anti-HER2/neu and anti-EGFR anthracycline immunoconjugates in chemotherapeutic-resistant mammary carcinoma combined with cyclosporin A and verapamil P-glycoprotein inhibition.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cyclosporine; Drug Resistance, Neoplasm; Epirubicin; ErbB Receptors; Female; Humans; Immunoconjugates; Immunoglobulin G; Receptor, ErbB-2; Verapamil | 2009 |
De novo phyllodes tumor in an adolescent female after liver transplantation.
Topics: Adolescent; Breast Neoplasms; Cyclosporine; Female; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Magnetic Resonance Imaging; Phyllodes Tumor; Recurrence; Remission Induction; Tacrolimus; Ultrasonography | 2011 |
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation.
Topics: Adult; Breast Neoplasms; Cyclosporine; Disease Progression; Estradiol; Female; Fibroadenoma; Follicle Stimulating Hormone; Humans; Immunosuppressive Agents; Kidney Transplantation; Mastectomy, Segmental; Middle Aged; Progesterone; Prolactin; Tacrolimus; Young Adult | 2010 |
Breast fibroadenomas associated with immunosuppressive drugs.
Topics: Adult; Biopsy, Fine-Needle; Breast Neoplasms; Cyclosporine; Female; Fibroadenoma; Humans; Immunohistochemistry; Immunosuppressive Agents; Kidney Transplantation; Mastectomy; Risk Assessment; Sampling Studies; Tacrolimus | 2010 |
Cyclosporine-induced fibroadenomatosis.
Topics: Breast Neoplasms; Cyclosporine; Female; Fibroadenoma; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Neoplasm Regression, Spontaneous; Ultrasonography, Mammary | 2011 |
Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclosporine; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Pyruvate Kinase | 2012 |
Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization.
Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldehyde Reductase; Aldo-Keto Reductase Family 1 Member C3; Aldo-Keto Reductases; Breast Neoplasms; Cell Nucleus; Cholic Acids; Cyclosporine; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Hydroxyprostaglandin Dehydrogenases; Intracellular Space; MCF-7 Cells; Oligonucleotide Array Sequence Analysis | 2012 |
Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Division; Cyclosporine; Drug Synergism; Female; Fenretinide; Humans; Immunosuppressive Agents; Nitric Oxide; Receptors, Estrogen; Tretinoin; Tumor Cells, Cultured | 2002 |
Pathologic quiz case: post-lung transplantation patient with bilateral breast masses.
Topics: Adult; Breast Neoplasms; Cyclosporine; Female; Fibroadenoma; Humans; Immunosuppressive Agents; Lung Transplantation; Neoplasms, Multiple Primary | 2003 |
Report of a renal transplanted patient with fibroadenoma occurring in a short time.
Topics: Adult; Azathioprine; Breast Neoplasms; Creatinine; Cyclosporine; Female; Fibroadenoma; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Steroids | 2003 |
Characteristic imaging features of breast fibroadenomas in women given cyclosporin A after renal transplantation.
Topics: Adolescent; Adult; Breast Neoplasms; Case-Control Studies; Cyclosporine; Female; Fibroadenoma; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Retrospective Studies; Risk Factors; Ultrasonography | 2004 |
Multiple bilateral fibroadenomas of the breasts requiring mastectomy in a renal transplant patient.
Topics: Adolescent; Breast Neoplasms; Cyclosporine; Female; Fibroadenoma; Humans; Immunosuppressive Agents; Kidney Transplantation; Mastectomy | 2004 |
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Breast Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Cytokines; Cytotoxicity, Immunologic; Fas Ligand Protein; Female; Gene Expression Regulation; Graft vs Host Disease; Granzymes; Humans; Lymphocyte Activation; Membrane Glycoproteins; Middle Aged; Perforin; Pore Forming Cytotoxic Proteins; Serine Endopeptidases; T-Lymphocytes, Cytotoxic; Transplantation, Autologous | 2004 |
Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A.
Topics: Acridines; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Cyclosporine; Female; HeLa Cells; Humans; Intracellular Membranes; Kinetics; Microsomes; Neoplasm Proteins; Recombinant Proteins; Substrate Specificity; Tetrahydroisoquinolines; Transfection | 2005 |
Cyclosporin A is a broad-spectrum multidrug resistance modulator.
Topics: Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Nucleus; Cells, Cultured; Cyclosporine; Cytoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; HL-60 Cells; Humans; Kidney; Mitoxantrone; Neoplasm Proteins; Vault Ribonucleoprotein Particles | 2005 |
Risk of developing fibroadenoma with the use of cyclosporine A in renal transplant recipients.
Topics: Adult; Biopsy, Needle; Breast Neoplasms; Cross-Sectional Studies; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibroadenoma; Follow-Up Studies; Humans; Immunohistochemistry; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Renal Dialysis; Risk Assessment; Transplantation Immunology | 2005 |
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cyclosporine; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Immunosuppressive Agents; Mitoxantrone; Neoplasm Proteins; Sirolimus; Substrate Specificity; Tacrolimus; Topotecan | 2006 |
NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2.
Topics: Breast Neoplasms; Cell Line, Tumor; Collagen; Cyclooxygenase 2; Cyclosporine; Dinoprostone; Drug Combinations; Humans; Ionomycin; Ionophores; Laminin; Neoplasm Invasiveness; Neoplasm Metastasis; NFATC Transcription Factors; Proteoglycans; RNA, Small Interfering; Tetradecanoylphorbol Acetate | 2006 |
First report of a fibro-adenoma in axillary mammary tissue of a renal transplant patient taking cyclosporin.
Topics: Adult; Axilla; Breast Neoplasms; Cyclosporine; Diagnosis, Differential; Female; Fibroadenoma; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation | 2007 |
Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis.
Topics: Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Biflavonoids; Breast Neoplasms; Caspases; Catechin; Cyclosporine; Humans; Membrane Potential, Mitochondrial; Mitochondria; Toluene; Transcriptional Activation; Tumor Suppressor Protein p53; Up-Regulation | 2008 |
Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A.
Topics: Animals; Breast Neoplasms; Carcinoma; Carrier Proteins; Chickens; Cyclosporine; DNA-Binding Proteins; Gene Transfer Techniques; Heat-Shock Proteins; Humans; Immunosuppressive Agents; Mice; Receptor Aggregation; Receptors, Progesterone; Tacrolimus; Tacrolimus Binding Proteins; Tumor Cells, Cultured | 1995 |
Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Cell Survival; Culture Media; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Stability; HL-60 Cells; Humans; Idarubicin; Intracellular Fluid; Tumor Cells, Cultured | 1995 |
Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Nucleus; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Neoplasm Proteins; Piperidines; Subcellular Fractions; Triazines; Tumor Cells, Cultured; Verapamil | 1995 |
Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation.
Topics: Adult; Azathioprine; Breast Neoplasms; Cohort Studies; Cyclosporine; Europe; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Logistic Models; Middle Aged; North America; Risk; Risk Factors; Steroids | 1995 |
[Effect of the modality of exposure on the action of S9788 on the modulation of multidrug resistance of human tumor cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Humans; Leukemia; Piperidines; Triazines; Tumor Cells, Cultured; Verapamil | 1994 |
Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
Topics: Antigens, CD; Bone Marrow Transplantation; Breast Neoplasms; Cyclosporine; Cytotoxicity, Immunologic; Gene Expression; Graft vs Host Disease; Histocompatibility Antigens Class I; HLA-D Antigens; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Myeloid, Acute; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Polymerase Chain Reaction; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Skin; T-Lymphocytes; Transplantation, Autologous | 1995 |
Selective toxicity of TGF-alpha-PE40 to EGFR-positive cell lines: selective protection of low EGFR-expressing cell lines by EGF.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Cell Line; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Epidermal Growth Factor; ErbB Receptors; Exotoxins; Female; Humans; Lung Neoplasms; Recombinant Fusion Proteins; Recombinant Proteins; Tamoxifen; Transforming Growth Factor alpha; Tumor Cells, Cultured; Verapamil | 1994 |
Clinical effects on CA 15-3 level of cyclosporin A as a chemosensitiser in chemoresistant metastatic breast cancer.
Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Bone Neoplasms; Breast Neoplasms; Cyclosporine; Drug Resistance; Epirubicin; Female; Humans; Middle Aged | 1993 |
Cyclosporin A potentiates estradiol-induced expression of the cathepsin D gene in MCF7 breast cancer cells.
Topics: Breast Neoplasms; Cathepsin D; Cyclosporine; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Gene Expression; Humans; Polyunsaturated Alkamides; Receptors, Estradiol; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured | 1996 |
Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer.
Topics: Adult; Bone Marrow Transplantation; Breast Neoplasms; Cyclosporine; Dermatitis, Exfoliative; Edema; Epidermis; Female; Gene Expression Regulation; Graft vs Host Disease; HLA-DR Antigens; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Keratinocytes; Survival Rate | 1996 |
Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; bcl-2-Associated X Protein; bcl-X Protein; Breast Neoplasms; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Molecular Sequence Data; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Tumor Cells, Cultured; Verapamil; Vincristine | 1996 |
Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil | 1995 |
The effects of cyclosporin A, tamoxifen, and medroxyprogesterone acetate on the enhancement of adriamycin cytotoxicity in primary cultures of human breast epithelial cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Epithelium; Humans; Medroxyprogesterone Acetate; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1996 |
Functional modulation of ATPase of P-glycoprotein by C219, a monoclonal antibody against P-glycoprotein.
Topics: Adenocarcinoma; Adenosine Triphosphatases; Adenosine Triphosphate; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Breast Neoplasms; Cell Line; Cell Membrane; Cyclosporine; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Kinetics; Tumor Cells, Cultured; Verapamil | 1997 |
Cyclosporin A and multiple fibroadenomas of the breast.
Topics: Adult; Breast Neoplasms; Carcinogens; Cohort Studies; Cyclosporine; Estradiol; Female; Fibroadenoma; Follicle Stimulating Hormone; Humans; Immunosuppressive Agents; Kidney Transplantation; Menstrual Cycle; Middle Aged; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin | 1996 |
Csa-19, a radiation-responsive human gene, identified by an unbiased two-gel cDNA library screening method in human cancer cells.
Topics: Age Factors; Blotting, Northern; Breast Neoplasms; Cloning, Molecular; Colforsin; Cyclosporine; DNA, Complementary; Dose-Response Relationship, Radiation; Down-Regulation; Gene Expression Regulation, Developmental; Gene Library; Genes, p53; HL-60 Cells; Humans; Molecular Sequence Data; Neutrons; Oncogenes; Tetradecanoylphorbol Acetate; Tissue Distribution; Tumor Cells, Cultured; X-Rays | 1997 |
Breast and lung cancers in two cyclosporin-A-treated psoriatic women.
Topics: Adult; Breast Neoplasms; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Middle Aged; Psoriasis | 1998 |
Short-term outcome of chronic immunosuppression on the development of breast lesions in premenopausal heart and lung transplant patients.
Topics: Adolescent; Adult; Azathioprine; Biopsy, Needle; Breast Neoplasms; Child; Chronic Disease; Cyclosporine; Female; Fibroadenoma; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Mammography; Middle Aged; Physical Examination; Premenopause; Preoperative Care; Retrospective Studies; Treatment Outcome | 1998 |
Gynaecomastia presenting as fibroadenomatoid tumours of the breast in a renal transplant recipient associated with cyclosporin treatment.
Topics: Adult; Breast Neoplasms; Cyclosporine; Female; Fibroadenoma; Humans; Immunosuppressive Agents; Kidney Transplantation; Phyllodes Tumor; Prednisolone | 1998 |
Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Assay; Breast Neoplasms; Cyclosporine; Female; Humans; Rhodamine 123; Sensitivity and Specificity; Verapamil | 1996 |
Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Ceramides; Cyclosporine; Cyclosporins; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Humans; Immunosuppressive Agents; Tamoxifen; Tumor Cells, Cultured | 1999 |
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.
Topics: Adult; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mice; Middle Aged; Neoplasm Metastasis; Radioimmunotherapy; Radiotherapy Dosage; Transplantation, Autologous; Yttrium Radioisotopes | 1999 |
[Chemosensitivity test for 170 human breast carcinoma samples].
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cisplatin; Cyclosporine; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Middle Aged; Paclitaxel; Tumor Cells, Cultured | 1998 |
Pyoderma gangrenosum following breast reconstruction.
Topics: Breast Neoplasms; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Mammaplasty; Middle Aged; Necrosis; Postoperative Complications; Pyoderma Gangrenosum; Surgical Flaps | 2000 |
Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P-glycoprotein-170.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Calcineurin; Calcineurin Inhibitors; Carcinoma; Cells, Cultured; Cyclosporine; Cyclosporins; Drug Resistance; Drug Tolerance; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; T-Lymphocytes; Tacrolimus; Tumor Cells, Cultured | 2000 |
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Breast Neoplasms; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Leukemia Effect; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA-B Antigens; HLA-DR6 Antigen; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Prospective Studies; Transplantation, Autologous | 2000 |
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)et
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cyclosporine; Female; Humans; Immunity; Immunologic Factors; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Organoplatinum Compounds; T-Lymphocytes; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |
[Prolactin as pro-inflammatory cytokine--considerations on consolidated immunotherapy after high dosage therapy].
Topics: Breast Neoplasms; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Prolactin | 2000 |
Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Apoptosis Regulatory Proteins; Bacterial Outer Membrane Proteins; bcl-X Protein; Breast Neoplasms; Carrier Proteins; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cyclosporine; Enzyme Activation; Fas-Associated Death Domain Protein; Genes, bcl-2; Humans; Jurkat Cells; Lipoproteins; Membrane Glycoproteins; Membrane Potentials; Mitochondria; Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Serpins; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; U937 Cells; Viral Proteins; X-Linked Inhibitor of Apoptosis Protein | 2001 |
Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cell Survival; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Mitoxantrone; Multidrug Resistance-Associated Proteins; RNA, Neoplasm; Sulfinpyrazone; Time Factors; Tumor Cells, Cultured | 2001 |
Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.
Topics: Adult; Base Sequence; Breast Neoplasms; CD8-Positive T-Lymphocytes; Clone Cells; Complementarity Determining Regions; Cyclosporine; Cytotoxicity Tests, Immunologic; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Immunoglobulin Joining Region; Immunoglobulin Variable Region; Lymphoma, Non-Hodgkin; Male; Middle Aged; Phenotype; Receptors, Antigen, T-Cell; T-Lymphocytes; Transplantation, Autologous | 2001 |
Cyclosporin A-induced fibroadenomas of the breast: report of five cases.
Topics: Adolescent; Adult; Breast Neoplasms; Cyclosporine; Diagnostic Imaging; Female; Fibroadenoma; Humans; Middle Aged; Organ Transplantation; Postoperative Complications | 2001 |
Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Mice; Mice, Nude; Paclitaxel; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous; Tubulin Modulators; Tumor Cells, Cultured; Vinblastine | 2002 |
Multiple bilateral giant fibroadenomas associated with cyclosporine A therapy in a renal transplant recipient.
Topics: Adult; Breast Neoplasms; Cyclosporine; Female; Fibroadenoma; Humans; Immunosuppressive Agents; Kidney Transplantation; Mammography | 2001 |
Successful treatment of postoperative pyoderma gangrenosum with cyclosporin.
Topics: Adult; Breast Neoplasms; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibroadenoma; Follow-Up Studies; Humans; Immunosuppressive Agents; Mammaplasty; Mastectomy; Postoperative Complications; Pyoderma Gangrenosum; Treatment Outcome; Wound Healing | 2002 |
Evaluation of a method for detection of cells with reduced drug retention in solid tumours.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Cell Survival; Chromatography, High Pressure Liquid; Culture Media; Cyclosporine; Daunorubicin; Drug Resistance; Female; Flow Cytometry; Friend murine leukemia virus; Humans; Hydrogen-Ion Concentration; Leukemia, Erythroblastic, Acute; Membrane Glycoproteins; Mice; Neoplasm Proteins; Neoplasms; Nephelometry and Turbidimetry; Reference Standards; Reproducibility of Results; Treatment Outcome; Tumor Cells, Cultured; Verapamil | 1992 |